Latest market price
8.88
+0.24+2.84%
OverviewShort InterestFilings
TDOCQT79Teladoc Health, Inc.·NYSE
8.88+2.84%
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
CERT+1.81%$10.90OMCL-2.69%$35.43GDRX-0.14%$3.54OMDA+4.26%$18.61HSTM-5.49%$32.68PRVA+1.34%$21.56PHR-0.80%$12.34SOPH-3.45%$6.87
Snapshot
Index—P/E—EPS (ttm)-0.86Insider Own1.52%Shs Outstand181.68MPerf Week38.30%
Market Cap1.57BForward P/E—EPS next Y-0.61Insider Trans-3.96%Shs Float180.37MPerf Month56.34%
Enterprise Value1.74BPEG—EPS next Q-0.12Short Float17.78%Perf Quarter28.61%
Income-155.00MP/S0.64EPS this Y—Short Ratio7.45Perf Half Y30.17%
Sales2.47BP/B1.21EPS next Y—ROA-5.58%Short Interest32.07MPerf YTD23.29%
Book/sh7.13P/C1.84EPS next 5Y—ROE-11.63%52W High9.89 -10.26%Perf Year-1.26%
Cash/sh4.68P/FCF6.73EPS past 3/5Y—ROIC-6.21%52W Low4.40 101.70%Perf 3Y-46.36%
Dividend Est.—EV/EBITDA7.39Sales past 3/5Y1.68% 18.26%Gross Margin73.18%Volatility9.15% 5.47%Perf 5Y-93.92%
Dividend TTM—EV/Sales0.71EPS Y/Y TTM—Oper. Margin-6.07%ATR (14)0.45Perf 10Y-47.85%
Dividend Ex-Date—Quick Ratio0.84Sales Y/Y TTM-2.33%Profit Margin-6.27%RSI (14)78.40Recom2.64
Dividend Gr. 3/5Y—Current Ratio0.87EPS Q/Q46.43%SMA2034.48%Beta1.93Target Price9.30
Payout0.00%Debt/Eq0.79Sales Q/Q-3.35%SMA5037.49%Rel Volume1.50Prev Close8.63
Employees5,124LT Debt/Eq0.02EarningsFeb 24SMA20033.18%Avg Volume4.03MPrice8.88
IPO DateJun 30, 2015Option/ShortYes / YesEPS/Sales Surpr.30.96% 2.88%Net Debt/EBITDA0.75Volume6,062,251Change2.84%
Analyst Ratings
DateActionAnalystRatingTarget
Nov-02-26ReiteratedPiper SandlerOverweight$13 → $11
Nov-02-26ReiteratedUBSNeutral$9.00
Jul-30-26ReiteratedJefferiesHold$9.00 → $8.00
Jul-30-26ReiteratedEvercore ISI GroupIn Line$6.00 → $7.50
Jul-21-26ReiteratedCanaccord GenuityBuy$11
Apr-08-26ReiteratedEvercore ISI GroupIn Line$9.00 → $6.00
Mar-10-26UpgradeDeutsche BankHold → Buy$18 → $11
Feb-26-26ReiteratedStifel NicolausHold$8.00 → $6.00
Feb-26-26ReiteratedWells FargoEqual Weight$6.00
Jan-16-26ReiteratedGoldman SachsBuy$9.00 → $8.00
Latest News· Times ET
Oct-29-26
Oct-29-2612:32PM
Teladoc Soars 26% as Revenue and Profit Beat Estimates; Hims & Hers Health and American Well Tick Up247wallst.com
11:30AM
Gap-Up and Gap-Down Stocks in the Oct. 29, 2026 SessionChartMill
07:30AM
Teladoc Stock Rallies After Double Beat; Lifts FY26 GAAP EPS Outlookbenzinga.com
05:18AM
Teladoc Health, Inc. (TDOC) Q3 2026 Earnings Call Transcriptseekingalpha.com
04:22AM
Cathie Wood Is Buying Archer Aviation Stock. Here's What History Says About Following Ark Into a Stock Down 62%.fool.com
04:06AM
Teladoc Health Q3 Earnings Call Highlightsmarketbeat.com
02:13AM
Teladoc: 3 Key Takeaways for Long-Term Investorsfool.com
Oct-28-26
Oct-28-2607:01PM
Teladoc (TDOC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimateszacks.com
06:46PM
Teladoc (TDOC) Reports Q3 Loss, Beats Revenue Estimateszacks.com
04:05PM
Teladoc Health Reports Third Quarter 2026 Resultsglobenewswire.com
Oct-27-26
Oct-27-2610:16AM
Unveiling Teladoc (TDOC) Q3 Outlook: Wall Street Estimates for Key Metricszacks.com
Oct-21-26
Oct-21-2609:19PM
What Does Progyny's Falling Multiple Really Say?Yahoo
Oct-19-26
Oct-19-2607:15PM
Teladoc (TDOC) Outperforms Broader Market: What You Need to Knowzacks.com
Oct-18-26
Oct-18-2604:09AM
Teladoc Health, Inc. $TDOC Shares Acquired by Counterpoint Mutual Funds LLCdefenseworld.net
Oct-14-26
Oct-14-2604:12PM
Teladoc, Carvana, Wayfair, DoorDash, and Coinbase Stocks Trade Down, What You Need To KnowYahoo
Company

Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,4682,5302,5702,602—————
Cost of Goods Sold Incl. D&A662772751760—————
Gross Profit1,8061,7581,8181,842—————
Selling, General and Administrative Excl. Other1,0911,0851,3461,367—————
Research and Development269278307349—————
Other Operating Expense5966581,186375—————
Operating Income-150-263-1,021-249—————
Interest Expense20202422—————
Unusual Expense
—————————
Non-Operating Income (Expense)11475151—————
Net Income Before Taxes-159-236-994-220—————
Income Taxes-3-3581—————
Consolidated Net Income-155-200-1,001-220—————
Net Income From Continuing Operations-155-200-1,001-220—————
Net Income-155-200-1,001-220—————
EPS (Recurring)-0.86-1.14-5.87-1.36—————
EPS (Basic, Before Extraordinaries)-0.86-1.14-5.87-1.36—————
EPS (Diluted)-0.86-1.14-5.87-1.34—————
EBITDA236147174138—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio
—————————
Price To Sales Ratio0.650.490.601.34—————
Gross Margin73.1869.4970.7470.79—————
Operating Margin-6.08-10.40-39.73-9.57—————
Net Margin-6.28-7.91-38.95-8.46—————
Shares Outstanding182176171162—————
Market Capitalization1,6151,2321,5543,491—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$10.51$8.80$7.09$5.39$3.68● Close Price0.00K172.65K345.30K517.94K690.59KUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Catapano Joseph RonaldChief Accounting OfficerOct 02 '26Sale5.656553,70314,293Oct 05
Catapano Joseph RonaldChief Accounting OfficerOct 01 '26Option Exercise0.002,083014,948Oct 05
DIVITA CHARLES IIICHIEF EXECUTIVE OFFICERSep 11 '26Sale6.1017,805108,682465,535Sep 14
DIVITA CHARLES IIICHIEF EXECUTIVE OFFICERSep 10 '26Option Exercise0.0042,8020483,340Sep 14
Rodrigues Fernando M.President of BetterHelpSep 03 '26Sale6.519,81263,8760Sep 03
DIVITA CHARLES IIICHIEF EXECUTIVE OFFICERSep 02 '26Sale6.3018,327115,478440,538Sep 03
Bliss KellyPresident, U.S. Group HealthSep 02 '26Sale6.307,35746,35692,832Sep 03
Rodrigues Fernando M.President of BetterHelpSep 02 '26Sale6.305,43934,2719,812Sep 03
Nueno CarlosPresident, InternationalSep 02 '26Sale6.306,20039,06664,744Sep 03
Vandervoort Adam CCHIEF LEGAL OFFICER, SECRETARYSep 02 '26Sale6.307,57347,717117,616Sep 03
Catapano Joseph RonaldChief Accounting OfficerSep 02 '26Sale6.302741,72612,865Sep 03
Rodrigues Fernando M.President of BetterHelpSep 01 '26Option Exercise0.0015,251015,251Sep 03
Nueno CarlosPresident, InternationalSep 01 '26Option Exercise0.0013,273070,944Sep 03
Vandervoort Adam CCHIEF LEGAL OFFICER, SECRETARYSep 01 '26Option Exercise0.0014,9280125,189Sep 03
Bliss KellyPresident, U.S. Group HealthSep 01 '26Option Exercise0.0015,3110100,189Sep 03
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.